Relatedly, severe congenital neutropenia (SCN), a disease marked by increased apoptosis of neutrophils and neutrophil precursors, and patients are treated with recombinant G-CSF (rG-CSF) are at increased risk of leukemogenesis (100). This evidence concerns the gene CSF3 and severe congenital neutropenia.